Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lifecare AS ( (DE:LFC0) ) has issued an announcement.
Lifecare ASA announced the commencement of the exercise period for over 4 million warrants issued in connection with a previous rights issue. Each warrant allows the holder to subscribe for a new share at a specified price, with the exercise period ending on June 13, 2025. Failure to exercise these warrants could result in a dilution of shareholding for the holders. The company expects the share capital increase to be registered by June 24, 2025, with new shares delivered to subscribers shortly after. This development is significant for Lifecare’s financial positioning and could impact shareholder value.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes. The company aims to bring the next generation of Continuous Glucose Monitoring (CGM) systems to market, utilizing osmotic pressure as a sensing principle. Their sensor technology is applicable for monitoring a wide range of analytes and molecules in humans and pets.
Average Trading Volume: 39,494
Current Market Cap: NOK98.61M
For detailed information about LFC0 stock, go to TipRanks’ Stock Analysis page.